Carlsquare advised the shareholders of 3verest, an Australian-owned, UK-headquartered leading provider of private and sovereign cloud infrastructure-as-a-service for healthcare IT, on its sale to ARCHIMED, a global investment firm focused exclusively on the healthcare sector. The transaction reflects the growing strategic importance of secure, jurisdiction-compliant cloud infrastructure as hospitals and diagnostic providers digitise imaging and adopt AI.
3verest is a UK-headquartered leading provider of private and sovereign cloud infrastructure-as-a-service for healthcare IT, with a focus on Radiology and Pathology. The company hosts clinical applications, medical-imaging data and AI workloads, with security and controls designed to keep sensitive data – and AI processing – within the required jurisdictions. Built without external funding, 3verest has developed a highly resilient recurring-revenue business model serving healthcare institutions in the US, UK and Australia. The company is led by its founder and CEO Scott Crawford, based in Australia, but North America accounts for ~60% of its revenue.
With offices in North America, Europe, the Middle East and Asia, ARCHIMED is a leading investment firm focused exclusively on healthcare industries. Its mix of operational, medical, scientific and financial expertise allows ARCHIMED to serve as both a strategic and financial partner to healthcare businesses. Prioritised areas of focus include Animal & Environmental Health, Biopharma Products, Consumer Health, Diagnostics, Healthcare IT, Life Science Tools & Services, and MedTech. ARCHIMED helps partners internationalise, acquire, innovate and expand their products and services. ARCHIMED manages €15 billion across its various funds. Since inception, ARCHIMED has been a committed impact investor, both directly and through its EURÊKA Foundation.
ARCHIMED has acquired a majority stake in 3verest from its founder, who will remain a significant shareholder and will continue to lead the company alongside its management team. The partnership gives 3verest access to ARCHIMED’s deep healthcare expertise, international network and experience in scaling a global organisation. As an ARCHIMED company, 3verest plans to accelerate its growth, broaden its cloud deployment beyond Radiology and Pathology, and expand its geographical footprint across the globe.
For ARCHIMED, the investment adds a specialised infrastructure platform to its HealthTech portfolio at a time of structural change in the market.
“Having built 3verest from scratch, finding the right partner for the next chapter of growth was critical. ARCHIMED understands both healthcare and the strategic importance of sovereign cloud infrastructure. Carlsquare guided us through a demanding, global process with persistence and excellent judgement.” – Scott Crawford, Founder & CEO, 3verest
“3verest has built a highly trusted infrastructure platform at the heart of digital radiology and pathology. We look forward to supporting the team as it scales internationally and helps healthcare providers adopt imaging and AI securely.” – Anthony Farias, Partner, ARCHIMED
Carlsquare acted as the exclusive financial advisor to the shareholders of 3verest.
